2
项与 Lyophilized and Micronized Particulate Human Amniotic and Umbilical Cord(TissueTech) 相关的临床试验A Phase 2 Randomized, Controlled, Multicenter, Dose Optimization Study of TTAX03 in the Treatment of Mild to Moderate Dry Eye Disease (DED)
The purpose of this randomized, controlled, multicenter study is to evaluate the safety and efficacy of TTAX03 in participants with mild to moderate DED.
The primary question it aims to answer is if TTAX03 is safe. The secondary is the effectiveness.
Researchers will compare 10mg of TTAX03 reconstituted in 150, 300, or 600 uL saline to the saline control group to look at effectiveness.
Participants will be randomized to a treatment group one time and be evaluated at 5 different study visits.
A Randomized, Phase 1 Dose Finding Study of TTAX03 for the Treatment of Lumbosacral Facet Joint Pain
This is a pilot study examining the safety and efficacy of a single intra-articular (IA) injection of TTAX03 per joint to relieve severe spinal facet joint (FJ) pain and improve function in subjects with facet joint pain (FJP) in the lumbosacral region. The design is randomized, double blinded, placebo controlled and dose-group sequential.
100 项与 Lyophilized and Micronized Particulate Human Amniotic and Umbilical Cord(TissueTech) 相关的临床结果
100 项与 Lyophilized and Micronized Particulate Human Amniotic and Umbilical Cord(TissueTech) 相关的转化医学
100 项与 Lyophilized and Micronized Particulate Human Amniotic and Umbilical Cord(TissueTech) 相关的专利(医药)
100 项与 Lyophilized and Micronized Particulate Human Amniotic and Umbilical Cord(TissueTech) 相关的药物交易